.Atea Pharmaceuticals' antiviral has fallen short one more COVID-19 test, but the biotech still hold...
.Neurocrine Biosciences' mental illness course pivot has neglected. The biotech was unable to reprod...
.Sanofi has actually made an overdue access to the radioligand gathering, paying for one hundred tho...
.After F2G's very first attempt to receive a brand-new class of antifungal to market was actually th...
.Moderna has actually pledged to reduce R&D spending by $1.1 billion by 2027. The decision to shr...
.Just 4 months after Sanofi bet $80 thousand in upfront money on Fulcrum Therapeutics' losmapimod, t...
.Cancer company Oncternal Therapies is actually folding all its scientific trials and also laying of...
.Roche is storing out hopes that its injectable being overweight prospect can at some point demonstr...
.Novo Nordisk has actually elevated the cover on a stage 1 test of its dental amylin as well as GLP-...
.Simply a handful of brief full weeks after succeeding an FDA Fast lane tag for its own investigatio...